Millie
your market intelligence analyst
Search Results
361 results
Your search is now limited to «Roche» expert search.
NASDAQ 12/11/2019 08:54
Roche Holding AG’s RHHBY subsidiary, Genentech, announced that the FDA has accepted the supplemental Biologics License Application (sBLA) for its allergic asthma drug, Xolair (omalizumab.
More from NASDAQ:
GlobeNewswire 12/11/2019 08:00
APHINITY six-year results strengthen evidence of clinical benefit with Roche’s Perjeta-based regimen Swiss Stock Exchange:RO.
More from GlobeNewswire:
FiercePharmaManufacturing 12/11/2019 00:55
RELATED: Roche's breast cancer hopes get a boost from postsurgery Kadcyla approval Still, the newest data could help Roche build Perjeta's case as an adjuvant treatment in HER2-positive breast cancer patients, an indication the FDA granted in late 2017 ...
More from FiercePharmaManufacturing:
Hoffmann-La Roche (EU) 12/10/2019 01:00
About Roche Diabetes Care Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years.
More from Hoffmann-La Roche (EU):
Reuters.com 12/09/2019 17:13
Claudia Böckstiegel, 55, will on April 1 take over Roche’s lead legal team role from current general counsel, Gottlieb Keller, the company said in a statement on Monday.
More from Reuters.com:
ENDPOINTS 12/09/2019 09:49
Roche today issued the latest in a long string of delays of its $4.3 billion buyout of Philadelphia-based Spark Therapeutics.
More from ENDPOINTS:
World Pharma News 12/09/2019 04:00
As previously disclosed by Roche and Spark, Roche notified its pending acquisition of Spark to the UK Competition and Markets Authority (the "CMA") on 18 October 2019.
More from World Pharma News:
FierceBiotech 12/09/2019 02:25
Roche rolled out new data this weekend showing mosunetuzumab can trigger complete responses in a tough group—lymphoma patients failed by CAR-Ts and other drugs.
More from FierceBiotech:
FP Trading Desk (Canada) 12/09/2019 01:13
ZURICH — Swiss drugmaker Roche again extended its offer for shares of gene therapy specialist Spark Therapeutics to Dec. 16 as a regulatory review of the $4.3 billion transaction drags on. All terms and conditions of Roche’s offer remain unchanged, it said in a statement on Monday. (Reporting by John Miller; editing by Thomas Seythal)
More from FP Trading Desk (Canada):
PR Newswire 12/04/2019 14:40
The Company and its consolidated subsidiaries, including the Offeror and Genentech, are referred to hereinafter as the "Roche Group.
More from PR Newswire:
Xconomy 12/04/2019 10:53
A Roche immunotherapy has won an additional FDA approval as a first-line treatment for non-small lung cancer, bolstering the product’s competitive stance versus one from Merck.
More from Xconomy:
Roche gets FDA nod for Tecentriq plus chemotherapy to treat NSCLC.
More from Pharmaceutical Business Review:
ETHealthWorld (India) 12/04/2019 02:10
Roche wins FDA approval for immunotherapy cocktail against lung cancer, Health News, ET HealthWorld.
More from ETHealthWorld (India):
Channel NewsAsia (Singapore) 12/04/2019 01:20
Roche wins FDA approval for immunotherapy cocktail against lung cancer.
More from Channel NewsAsia (Singapore):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications